Northwest Healthcare Properties Real Estate Investment Trust Reports Second Quarter 2025 Results, Suspends Its Distribution Reinvestment Plan, and Appoints Zachary Vaughan to the Board of Trustees

Executive Summary

• Northwest Healthcare Properties REIT reported Q2 2025 financial results, showing a return to net income of $32.6 million compared to a net loss in the prior year period, driven by reduced interest expenses and fair value gains on investment properties.
• The REIT announced the suspension of its Distribution Reinvestment Plan (DRIP) due to the unit price trading at a discount to net asset value, with cash distributions resuming for enrolled unitholders starting September 2025.
• Significant operational updates include the resolution of rent deferral issues with major tenant Healthscope Pty Ltd (HSO), the completion of over $231 million in asset dispositions, and a reduction in leverage to 48.5%.

Key Details

• Financial Performance (Q2 2025):
  • Net Income: $32.6 million (vs. net loss of $127.2 million in Q2 2024).
  • Revenue from Investment Properties: $99.0 million (down 16.9% YoY due to dispositions, offset by same-property growth).
  • Same Property Net Operating Income (SPNOI): $73.2 million, up 2.8% YoY.
  • Adjusted Funds From Operations (AFFO): $0.10 per unit (vs. $0.09 in Q2 2024); AFFO Payout Ratio: 88%.
  • Fair Value Adjustments: Recorded $13.6 million in gains on investment properties (vs. $172.4 million loss in Q2 2024).
• Balance Sheet & Leverage:
  • Leverage (Debt to Gross Book Value): 48.5% (down from 50.0% at Dec 31, 2024).
  • Portfolio Cap Rate: 6.3%.
  • Occupancy: 97% (Global portfolio); Weighted Average Lease Expiry (WALE): 13.5 years.
• Disposition Activity:
  • Total proceeds from capital recycling (Q2 2025 and subsequent events): Over $231 million.
  • Sale of Assura shares: $209.3 million in proceeds, resulting in a gain of ~$32.3 million; proceeds used to repay debt.
  • Sale of three other properties (North America, Europe, Australasia): $22.1 million in proceeds.
  • Assets Held for Sale: One income-producing property valued at $34.3 million as of June 30, 2025.
• Tenant & Operational Updates (Healthscope Pty Ltd - HSO):
  • HSO entered receivership in May 2025; all hospitals continue to operate.
  • Rent Deferral Resolution: Receiver repaid 50% of accrued deferred rent; new arrangement defers 10% of ongoing rent starting July 1, 2025.
  • Repayment Terms: Deferred rent to be repaid by March 31, 2026 or upon asset sale; deferred rent has priority over senior debt.
  • Sale Process: Receiver-led sale commenced late July 2025; new owner expected in Q4 2025.
• Financing Activity:
  • Revolving Credit Facility Amendment (July 29, 2025): Maturity extended to July 2027; moved to grid pricing reducing borrowing cost by 65 basis points; added $100 million accordion commitment.
  • Debt Repayment: Repaid $40.8 million in Canadian mortgages (weighted avg rate 2.67%) using revolving credit facility capacity.
  • Maturity Profile: ~$226 million of 2026 maturities due in Q4 2026; ~$230 million available liquidity.
• Corporate Actions:
  • DRIP Suspension: Suspended until further notice; unitholders receive cash distributions commencing September 2025 distribution.
  • Board Appointment: Zachary Vaughan appointed to Board of Trustees effective August 12, 2025.

Notable Quotes

• "Our Q2 2025 results reflect continued operational momentum, with improvements in AFFO per unit, a lower payout ratio, and continued execution of our capital recycling strategy with over $282 million in non-core asset sales completed year to date." – Zachary Vaughan, CEO
• "The REIT's unit price continues to trade at a meaningful discount to net asset value ("NAV") per unit, and the issuance of units under the DRIP runs counter to the REIT's focus of optimizing capital structure and driving superior growth in NAV per unit and returns over time." – Northwest Healthcare Properties REIT